John Allen

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

PMV’s $79.4m cash pile now hinges on rezatapopt’s 2027 ovarian cancer FDA bid

NFI Group’s backlog shrank 10.6% as earnings surged. How can both be true?

Frontera Energy’s post-divestment strategy is shifting toward infrastructure growth, with Puerto Bahía, its ODL pipeline stake and a planned LNG regasification project expected to drive future cash flow after the company returned C$590 million to shareholders. Representative image.

Frontera Energy (TSX: FEC) Q2 puts early-2027 LNG launch in focus

Shell’s Wild Coast offshore exploration plans have suffered a major setback after South Africa’s Constitutional Court blocked the disputed exploration right, sharpening scrutiny of how the country balances energy investment with environmental safeguards and community consultation. Representative image.

Shell plc (LSE: SHEL) blocked from Wild Coast exploration as South Africa faces investment test

Bluestone Investment Partners is backing Delphinus Engineering’s naval maintenance expansion as Roby Lentz succeeds founder Ranjit Das and leads its acquisition-driven growth strategy. Representative image.

Bluestone is backing 700-worker Delphinus. Can Roby Lentz build a naval maintenance platform?

Bluestone Investment Partners is pairing an insider-led succession with fresh capital and an acquisition strategy aimed at expanding Delphinus Engineering across the U.S. naval maintenance market.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF
Zynga

July 22, 2026